News
The global US Digital Pathology Market is projected to reach US$2.01 billion by 2029 from US$1.05 billion in 2024, at a CAGR ...
Opinion
Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled AkoyaKent Lake PR LLC ("Kent Lake") is a holder of approximately 7.5% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX). Today, Kent Lake issued a ...
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.
SAMBAI Selects Akoya’s PhenoCycler-Fusion Spatial Proteomics Technology for Large-Scale Cancer Study
Breast, pancreatic, and prostate cancers have a disproportionately higher rate of aggressive tumor grade in the target ...
Playa Hotels & Resorts N.V. (NASDAQ: PLYA ) , relating to the proposed merger with Hyatt Hotels Corporation. Under the terms of the agreement, Hyatt will acquire all outstanding shares of Playa for ...
Quanterix sees growth with Akoya acquisition, but rising losses and investor skepticism persist. Explore challenges and ...
Akoya Biosciences (AKYA) and SAMBAI announced that Akoya’s PhenoCycler-Fusion system will be the foundational spatial proteomics technology ...
Pentagon says Guam could be 1st target of Chinese missiles during Taiwan invasion ...
Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) saw a large decline in short interest in March. As of March 15th, there was short interest totalling 2,490,000 shares, a decline of 30.8% from ...
Akoya Biosciences (NASDAQ:AKYA – Get Free Report)‘s stock had its “equal weight” rating restated by stock analysts at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results